Showing results (111-120 of 259) with videos related to

Sort By:
Pageof 26
Blood Advances|November 8, 2018
Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemiaZachary R Hunter, Lian Xu, Nickolas Tsakmaklis, et al.
The New England Journal of Medicine|August 31, 2012
MYD88 L265P somatic mutation in Waldenström's macroglobulinemiaSteven P Treon, Lian Xu, Guang Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Lenalidomide and rituximab in Waldenstrom's macroglobulinemiaSteven P Treon, Jacob D Soumerai, Andrew R Branagan, et al.
American Journal of Hematology|December 24, 2019
Deepening of response after completing rituximab-containing therapy in patients with Waldenstrom macroglobulinemiaJorge J Castillo, Joshua N Gustine, Andrew Keezer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequencesJitra Kriangkum, Brian J Taylor, Steven P Treon, et al.
Blood Advances|July 17, 2025
Ibrutinib plus rituximab versus ibrutinib monotherapy in patients with Waldenström macroglobulinemia: A pooled analysisAlberto Guijosa, Andres Ramirez-Gamero, Shayna Sarosiek, et al.
Expert Review of Hematology|October 31, 2023
New developments in the diagnosis and characterization of Waldenström's macroglobulinemiaRamón García-Sanz, Zachary R Hunter, Stéphanie Poulain, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 12, 2013
microRNA aberrations in Waldenström macroglobulinemiaAntonio Sacco, Yong Zhang, Patricia Maiso, et al.
Journal of the American Academy of Dermatology|December 25, 2019
Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor-induced dermatologic adverse eventsSean Singer, Sally Y Tan, Anna K Dewan, et al.
Ejhaem|September 2, 2022
A pilot study on dasatinib in patients with Waldenström macroglobulinemia progressing on ibrutinibJorge J Castillo, Shayna Sarosiek, Catherine A Flynn, et al.
Pageof 26